The Patent Finder

AbbVie Biotechnology Ltd.

50 patents currently held · Updated Nov 16, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

33
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 21, 2027
    The maintenance fee for Anti-Tnf Antibody Formulations (US 9,085,619) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
  • 1 fee due May 10, 2027
    The maintenance fee for Wearable automatic injection device for controlled delivery of therapeutic agents (US 9,180,244) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Quinazolinones as PARP14 Inhibitors (US 10,562,891) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
  • 2 fees due Sep 8 to 15, 2027 · next Sep 8
  • 1 fee due Oct 16, 2027
    The maintenance fee for Quinazolinones as PARP14 Inhibitors (US 11,958,837) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
  • 1 fee due Nov 10, 2027
    The maintenance fee for METHODS OF TREATING MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA WITH ANTI-TNFalpha ANTIBODY (US 9,334,320) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,061,005Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US D677,380Automatic injection device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,486,584Automatic injection device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,231,876Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,883,156Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,895,009Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,906,372Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,916,153Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,096,666Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,102,723Purified antibody composition
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
Also on record, not counted in the 50: 3 patents in force now held by others · 9 lapsed for an unpaid fee · 58 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 16 abandoned · 51 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited